List of works - Yam Nath Paudel

2-[(4-Chlorobenzyl) amino]-4-methyl-1,3-thiazole-5-carboxylic acid exhibits antidiabetic potential and raises insulin sensitivity via amelioration of oxidative enzymes and inflammatory cytokines in streptozotocin-induced diabetic rats

scientific article published on 2 March 2017

A Perspective on the Impact of COVID-19 Pandemic on Basic Science Research and its Future Implications

scientific article published in 2021

Animal Models of Metabolic Epilepsy and Epilepsy Associated Metabolic Dysfunction: A Systematic Review

scientific article published on 26 May 2020

Arylsulfatase A (ASA) in Parkinson's Disease: From Pathogenesis to Biomarker Potential

scientific article published on 07 October 2020

EGFR tyrosine kinase inhibition decreases cardiac remodeling and SERCA2a/NCX1 depletion in streptozotocin induced cardiomyopathy in C57/BL6 mice

scientific article published on 11 August 2018

Effect of escitalopram and carbidopa on bone markers in Wistar rats: a preliminary experimental study

scientific article published on 29 January 2018

Embelin Prevents Seizure and Associated Cognitive Impairments in a Pentylenetetrazole-Induced Kindling Zebrafish Model

scientific article published on 17 April 2019

Emerging Pathogenic and Prognostic Significance of Paired Box 3 (PAX3) Protein in Adult Gliomas

scientific article published on 25 July 2019

Emerging neuroprotective effect of metformin in Parkinson's disease: A molecular crosstalk

scientific article published on 13 December 2019

Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling

scientific article published on 20 June 2019

Envisioning the neuroprotective effect of Metformin in experimental epilepsy: A portrait of molecular crosstalk

scientific article published on 23 July 2019

Evaluation of 4-methyl-2-[(2-methylbenzyl) amino]-1,3-thiazole-5-carboxylic acid against hyperglycemia, insulin sensitivity, and oxidative stress-induced inflammatory responses and β-cell damage in the pancreas of streptozotocin-induced diabetic rat

scientific article published in January 2017

Exploring the role of high-mobility group box 1 (HMGB1) protein in the pathogenesis of Huntington's disease

scientific article published on 08 February 2020

Flotillin: A Promising Biomarker for Alzheimer's Disease

scientific article published on 26 March 2020

Guggulsterone, a farnesoid X receptor antagonist lowers plasma trimethylamine-N-oxide levels: An evidence from in vitro and in vivo studies

scientific article published on 09 December 2018

HMGB1-Mediated Neuroinflammatory Responses in Brain Injuries: Potential Mechanisms and Therapeutic Opportunities ⬇️

scientific article published on 29 June 2020

HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction

scientific article published on 11 September 2018

High mobility group box 1 (HMGB1) as a novel frontier in epileptogenesis: from pathogenesis to therapeutic approaches

scientific article published on 12 February 2019

High mobility group box 1 (HMGB1) protein in Multiple Sclerosis (MS): Mechanisms and therapeutic potential

scientific article published on 10 October 2019

Impact of HMGB1, RAGE, and TLR4 in Alzheimer's Disease (AD): From Risk Factors to Therapeutic Targeting

scientific article published on 07 February 2020

Increased ACh-Associated Immunoreactivity in Autonomic Centers in PTZ Kindling Model of Epilepsy

scientific article published on 08 May 2020

Lymphocyte-Activation Gene 3 (LAG3) Protein as a Possible Therapeutic Target for Parkinson's Disease: Molecular Mechanisms Connecting Neuroinflammation to α-Synuclein Spreading Pathology

scientific article published on 23 April 2020

Pilocarpine Induced Behavioral and Biochemical Alterations in Chronic Seizure-Like Condition in Adult Zebrafish

scientific article published on 03 April 2020

Potential Neuroprotective Effect of the HMGB1 Inhibitor Glycyrrhizin in Neurological Disorders

scientific article published on 04 February 2020

Revisiting the Impact of Neurodegenerative Proteins in Epilepsy: Focus on Alpha-Synuclein, Beta-Amyloid, and Tau

scientific article published on 12 June 2020

Role of inflammation in epilepsy and neurobehavioral comorbidities: Implication for therapy

scientific article published on 17 August 2018

Tau Related Pathways as a Connecting Link between Epilepsy and Alzheimer's Disease

scientific article published on 30 September 2019

Unraveling the Role of Receptor for Advanced Glycation End Products (RAGE) and Its Ligands in Myasthenia Gravis

scientific article published on 13 February 2020

miR-124 and Parkinson's disease: A biomarker with therapeutic potential

scientific article published on 07 November 2019

List of works by Yam Nath Paudel